IDEX Corporation Continues Strategic Capital Deployment with Agreement to Acquire Iridian Spectral Technologies, a Global Leader in Thin-film Dielectric Optical Filters

IDEX Corporation (NYSE:IEX) today announced it has entered into a definitive agreement to acquire Iridian Spectral Technologies (“Iridian”) for cash consideration of 150 million Canadian dollars (“CAD”), subject to customary adjustments. The acquisition complements existing IDEX optical coating expertise, allowing IDEX…

Read MoreIDEX Corporation Continues Strategic Capital Deployment with Agreement to Acquire Iridian Spectral Technologies, a Global Leader in Thin-film Dielectric Optical Filters

Lumicell™ DVS Pivotal Trial Results Published in NEJM Evidence and to Be Presented at ASBrS Assess Safety and Effectiveness of System for Identifying Residual Breast Cancer During Lumpectomy

 A privately held company focused on innovative fluorescence-guided imaging technologies for cancer surgery, today announced that results of the Investigation of Novel Surgical Imaging for Tumor Excision (INSITE) pivotal trial have been published online in NEJM Evidence and will be presented at…

Read MoreLumicell™ DVS Pivotal Trial Results Published in NEJM Evidence and to Be Presented at ASBrS Assess Safety and Effectiveness of System for Identifying Residual Breast Cancer During Lumpectomy

Generate:Biomedicines and MD Anderson Enter Co-Development and Commercialization Agreement to Accelerate Novel Protein Therapeutics for Oncology Using Generative AI

Generate:Biomedicines and The University of Texas MD Anderson Cancer Center today announced a strategic collaboration to jointly discover and co-develop protein therapeutics for up to five oncology targets in advanced cancers, including small-cell and non-small-cell lung cancer. Under the co-development…

Read MoreGenerate:Biomedicines and MD Anderson Enter Co-Development and Commercialization Agreement to Accelerate Novel Protein Therapeutics for Oncology Using Generative AI

LeanTaaS Earns Highest Ratings in Inaugural KLAS Capacity Optimization Management Report

The market leader in providing AI-powered and SaaS-based capacity management, staffing, and patient flow software for health systems, today announced it has been named the highest, fully-rated company in the first-ever capacity optimization report by KLAS Research. Across LeanTaaS’ large customer…

Read MoreLeanTaaS Earns Highest Ratings in Inaugural KLAS Capacity Optimization Management Report

Surescripts to Present New Data on Opportunities to Expand Access & Fill Gaps in Primary Care and More at NCPDP 2023 Annual Technology & Business Conference

Surescripts, the nation’s leading health information network, will lead two sessions at the National Council for Prescription Drug Programs (NCPDP) Annual Technology & Business Conference on May 9, 2023, on Opportunities to Expand Access & Fill Gaps in Primary Care and Improving Sig Clarity: Tools…

Read MoreSurescripts to Present New Data on Opportunities to Expand Access & Fill Gaps in Primary Care and More at NCPDP 2023 Annual Technology & Business Conference

Nuvo Group Ltd., A Leading FDA-Cleared Innovator in Pregnancy Care, and LAMF Global Ventures Corp I, Led by Chairman Jeffrey Soros and CEO Simon Horsman, Announce Intent to List Nuvo on Nasdaq Through a Business Combination

Nuvo Group Ltd. (“Nuvo” or “the Company”), the creators of INVU by Nuvo™, an FDA-cleared remote pregnancy monitoring platform, and LAMF Global Ventures Corp I (NASDAQ: LGVC) (“LAMF”), a special purpose acquisition company (“SPAC”), today announced that they have entered…

Read MoreNuvo Group Ltd., A Leading FDA-Cleared Innovator in Pregnancy Care, and LAMF Global Ventures Corp I, Led by Chairman Jeffrey Soros and CEO Simon Horsman, Announce Intent to List Nuvo on Nasdaq Through a Business Combination

LE SYSTÈME DE SGC EN TEMPS RÉEL (SGCtr) DEXCOM G6 EST MAINTENANT COUVERT PAR LE PROGRAMME DES SSNA POUR TOUS LES CLIENTS ATTEINTS DE DIABÈTE ADMISSIBLES QUI PRENNENT DE L’INSULINE

Dexcom, Inc. (NASDAQ : DXCM), un chef de file à l’échelle internationale dans le domaine de la surveillance du glucose en continu (SGC) et en temps réel pour les personnes atteintes de diabète, se réjouit de l’élargissement progressif de la…

Read MoreLE SYSTÈME DE SGC EN TEMPS RÉEL (SGCtr) DEXCOM G6 EST MAINTENANT COUVERT PAR LE PROGRAMME DES SSNA POUR TOUS LES CLIENTS ATTEINTS DE DIABÈTE ADMISSIBLES QUI PRENNENT DE L’INSULINE